Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

Wed, 26th Apr 2023 17:03

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight.

In London, the FTSE 100 was hurt by share price falls for pharmaceutical stocks and building materials company CRH. Housebuilders and banking shares climbed, however.

The FTSE 100 index ended down 38.49 points, or 0.5%, at 7,852.64. The FTSE 250 fell just 7.42 points to 19,207.97. The AIM All-Share closed down 2.42 points, or 0.3%, at 821.84.

The Cboe UK 100 ended down 0.6% at 785.31, the Cboe UK 250, however, added 0.2% at 16,842.98. The Cboe Small Companies lost 0.2% at 13,293.67.

Stocks in New York were mixed on Wednesday. The Dow Jones Industrial Average was down 0.1%, while the S&P 500 index was up 0.3%, and the Nasdaq Composite surged 1.2%.

The tech-focused Nasdaq was an outlier in an otherwise tepid day for major indices.

Helping to boost the Nasdaq was a 7.8% share price rise for Microsoft.

It reported late Tuesday increased revenue and earnings in its financial third quarter, boosted by solid growth in its cloud division.

However, it received a blow on Wednesday after the UK's antitrust watchdog prevented its deal to acquire video game maker Activision Blizzard. Activision was down 11% in New York.

Microsoft said it would appeal the decision, and said the Competition & Markets Authority's decision reflects a "flawed understanding of this market and the way relevant cloud technology actually works".

The CMA said deal was blocked to "protect innovation and choice in cloud gaming".

In European equities on Wednesday, the CAC 40 in Paris closed down 0.9%, while the DAX 40 in Frankfurt ended down 0.5%.

"For today, the luxury sector appears to be seeing some profit-taking with Kering lower along with LVMH, Hermes, and Burberry weighing on the wider market, helping to push the CAC 40 sharply lower.

The FTSE 100 is also under pressure with the weakness very much broad-based across various sectors, with defensives feeling the pressure along with cyclicals, with health care a particular drag," CMC Markets analyst Michael Hewson commented.

In Paris, LVMH and Hermes each lost 1.6% and Kering gave back 2.3%. The latter late Tuesday reported first-quarter sales growth, though the Gucci owner's progress fell well short from growth seen from its peers. In London, Burberry fell 1.9%.

GSK and AstraZeneca lost 4.0% and 3.9%. The former reported a slip in quarterly sales on Wednesday. Astra reports on Thursday.

GSK said its top-line shrunk by 3.3%, reflecting less Covid-19 solution sales compared to the previous year.

Also hurting the FTSE 100, CRH fell 3.3%. It backed its half-year outlook but noted a challenging environment in Europe.

The building materials company said that reported sales in the first quarter of 2023 were up 7% year-on-year.

However, the company expects a more challenging backdrop in Europe, driven by continued inflationary pressures and some slowdown in the new-build residential sector.

Reckitt fell 2.6%. The consumer goods firm reported that price hikes supported its first-quarter outturn, though volumes slid.

The company said volumes fell 4.5% on-year in the first quarter of 2023, though it logged price/mix improvements of 12%. Reckitt said total net revenue in the first quarter rose 14% year-on-year to GBP3.92 billion from GBP3.42 billion a year earlier, or 7.9% on a life-for-like basis.

Unilever fell 0.9% in a negative read across. It reports a first-quarter trading statement on Thursday.

Housebuilders were on the up, however, lifted by an encouraging update from Persimmon. Persimmon closed up 5.1%.

The housebuilder said it expects to reach the top end of its 2023 expectations, despite a drop in sales in the first quarter on an annual basis.

Numbers suggest that the housing market has picked up from the fourth quarter, however.

It reported net private sales per outlet of 0.62, down 37% from 0.98 a year ago, but up from 0.30 in the final quarter of 2022.

The firm noted that forward sales also dropped on a yearly basis to GBP1.7 billion, 30% less than GBP2.4 billion the year prior, but up compared to GBP1.0 billion in the final quarter of 2022.

Persimmon said it expects full-year new home completions at the top end of its 8,000-9,000 guidance, "if sales rates continue around the level seen year to date".

Crest Nicholson and Redrow climbed 7.0% and 4.5%, respectively, in a positive read-across.

Standard Chartered added 2.8% on improved first-quarter earnings, bolstered by rate hikes.

The Asia-focused bank reported pretax profit of USD1.81 billion, up 21% from USD1.49 billion year-on-year.

Operating income climbed 6.2% to USD4.56 billion from USD4.29 billion. This was helped by net interest income rising 13% year-on-year to USD2.01 billion from USD1.78 billion, as it benefited from rising interest rates.

In addition, the company said it plans to return "in excess" of USD5 billion to shareholders by 2024.

Shares in banking sector peer Barclays, which reports on Thursday, climbed 1.7%.

Elsewhere in London, Warpaint added 7.1%.

The cosmetics supplier, which owns W7 and Technic makeup brands, said pretax profit multiplied in 2022 to GBP7.7 million from GBP3.7 million in 2021, driven by a 28% increase in revenue to GBP64.1 million from GBP50.0 million.

Looking ahead, Warpaint said trading has remained strong so far in 2023. Revenue in the first quarter was GBP18.5 million, up 40% from GBP13.2 million a year before, while margin improved on the 2022 full-year result.

The pound was quoted at USD1.2472 late Wednesday afternoon in London, higher compared to USD1.2404 at the London equities close on Tuesday. The euro stood at USD1.1046, higher against USD1.0983. Against the yen, the dollar was trading at JPY133.54, lower compared to JPY133.98.

The dollar suffered as Federal Reserve tightening expectations eased, though a hike next week still looks likely.

Fed tightening expectations eased after poor results from First Republic Bank reminded markets of the stress being felt by some US regional banks.

According to the CME FedWatch tool, there is an 81% chance that the central bank lifts rates by 25 basis points to a range of 5.00%-5.25% on Wednesday next week. The Fed is expected to pause hikes thereafter.

Still to come on Wednesday are results from Facebook owner Meta Platforms. Online retailer Amazon and pharmaceutical firm Merck & Co report on Thursday.

Aside from updates from AstraZeneca, Barclays and Unilever, the UK corporate diary has annual results from grocer Sainsbury's and a trading statement from advertising company WPP on Thursday.

The economic calendar has a US gross domestic product reading at 1330 BST.

Brent oil was quoted at USD80.29 a barrel late Wednesday, down from USD80.52 late Tuesday. Gold was quoted at USD1,995.53 an ounce, up against USD1,987.63.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.